HIGHLIGHT DETAIL
重要成果詳細內容

CXCL10/IP-10 is a Biomarker and Mediator for Kawasaki Disease.
Nat Commun., Mar 05, 2015Anticancer therapies are often compromised by nonspecific effects and challenged by tumour environments' inherent physicochemical and biological characteristics. Often, therapeutic effect can be increased by addressing multiple parameters simultaneously.
Journal Link 期刊連結